Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Teva
US Department of Justice
Citi
Medtronic
Baxter
Moodys
Boehringer Ingelheim
Argus Health

Generated: December 14, 2018

DrugPatentWatch Database Preview

Stuart Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for STUART PHARMS, and what generic and branded alternatives to STUART PHARMS drugs are available?

STUART PHARMS has one approved drug.



Summary for Stuart Pharms
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Stuart Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Stuart Pharms BUCLADIN-S buclizine hydrochloride TABLET;ORAL 010911-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Cipla
Harvard Business School
Express Scripts
Merck
Chubb
Julphar
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.